PTCT - PTC Therapeutics down 10% as EMA issues Translarna negative opinion
2024-01-25 17:30:32 ET
More on PTC Therapeutics
- PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript
- PTC Therapeutics says total unaudited FY23 net revenue was about $946M
- PTC Therapeutics issues EU, US regulatory updates on Translarna
- Seeking Alpha’s Quant Rating on PTC Therapeutics
- Historical earnings data for PTC Therapeutics